Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar JonAtkins57 (< 20) Submitted: 5/28/08 5:03 PM : Outperform Start Price: $12.12 ALKS Score: 20.93

Market Cap > 1B and < 2.5B
P/E Ratio < 20
Div Yield % < 1
Current Ratio > 0
Last Price < 20
Net Profit Margin % > 25

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links